IADR Abstract Archives

The Staining Potential of Various Currently-Marketed Mouthrinses

OBJECTIVES: The primary objective of this clinical trial was to determine the amount of tooth staining of four currently-marketed mouthrinses, as measured by the Macpherson modification of the Lobene Stain Index, when used over a 12 week period. The secondary objective was to determine the degree of taste alteration as determined through subject query.

METHODS: This investigation consisted of a 12-week, observer-blind, single-center, randomized comparison of five parallel groups of subjects. 180 subjects granting their informed consent entered the trial and 171 completed. Subjects were randomized to 1 of 4 currently-marketed mouthrinses Crest ProHealth, Cepacol, Scope, Viadent or brushing alone with a currently-marketed fluoride toothpaste and stratified with respect to smoking status. Upon randomization, subjects received a baseline stain score and then a prophylaxis to remove all extrinsic stain. Clinical assessments were repeated after 6 weeks and 3 months of product use and subjects were asked to complete a questionnaire at baseline, day 4, day 14, 6 weeks and 12 weeks post baseline to assess potential taste alteration.

RESULTS: Crest ProHealth and Cepacol resulted in significantly more extrinsic stain (p<0.001) after six weeks of use versus brushing alone with fluoride toothpaste. Crest ProHealth, Cepacol (p<0.001) and Scope (p=0.01) resulted in significantly more stain versus brushing alone after 12 weeks. Viadent was not significantly different from brushing alone at either timepoint. Up to 53% of subjects using Crest ProHealth mouthrinse experienced taste interference for up to three hours post-rinse after using the product as directed for 6 weeks. CONCLUSIONS: The results of this study demonstrated that regular use of Crest ProHealth and Cepacol mouthrinses resulted in extrinsic stain accumulation after 6 weeks with increased accumulation after 12 weeks versus brushing alone.


Division: AADR/CADR Annual Meeting
Meeting: 2010 AADR/CADR Annual Meeting (Washington, D.C.)
Location: Washington, D.C.
Year: 2010
Final Presentation ID: 108
Abstract Category|Abstract Category(s): Oral Health Research
Authors
  • Lisante, Tonianne  ( Johnson & Johnson Consumer & Personal Products Worldwide, Division of Johnson & Johnson Consumer Companies Inc, Morris Plains, NJ, USA )
  • Askinazi, Jodi A.  ( Johnson & Johnson Consumer & Personal Products Worldwide, Division of Johnson & Johnson Consumer Companies Inc, Morris Plains, NJ, USA )
  • Mcguire, James A.  ( Johnson & Johnson Consumer & Personal Products Worldwide, Division of Johnson & Johnson Consumer Companies Inc, Morris Plains, NJ, USA )
  • Hee, Angela  ( Johnson & Johnson Consumer & Personal Products Worldwide, Division of Johnson & Johnson Consumer Companies Inc, Morris Plains, NJ, USA )
  • Williams, Kathleen P.  ( RDH Independent Consultant, Flourtown, PA, USA )
  • SESSION INFORMATION
    Oral Session
    Prevention and Treatment of Oral Diseases I
    03/04/2010